• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HMD

HERAMED LIMITED

0.00% ! 1.5¢
Market Cap $13.13M  !
Healthcare Medical Devices
Add to My Watchlist

Hera Med Ltd is an Israel-based company that develops pregnancy monitoring solutions for... Hera Med Ltd is an Israel-based company that develops pregnancy monitoring solutions for home and professional use. It offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetus’ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The Company also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
HMD
Ann: HeraMED to present at NWR Virtual Healthcare Conference 		20/03/25 2 488
20/03/25 Last post  thecableguy Comments Created with Sketch.  2  Views Created with Sketch.  488 
HMD
Ann: Annual Report to shareholders 		14/03/25 3 1.1K
14/03/25 Last post  Hensabens Comments Created with Sketch.  3  Views Created with Sketch.  1.1K 
HMD
Ann: Appendix 4G and Corporate Governance Statement 		28/02/25 0 174
28/02/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  174 
HMD
Ann: Preliminary Final Report 		28/02/25 0 197
28/02/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  197 
HMD
Ann: Strategic Collaboration Agreement with Garmin Health 		26/02/25 12 2.9K
26/02/25 Last post  Kyriaco Comments Created with Sketch.  12  Views Created with Sketch.  2.9K 
HMD
Ann: Investor presentation 		20/02/25 2 773
20/02/25 Last post  barmy44 Comments Created with Sketch.  2  Views Created with Sketch.  773 
HMD
Ann: Change of Director's Interest Notice - AG 		18/02/25 4 1.0K
18/02/25 Last post  geffa9 Comments Created with Sketch.  4  Views Created with Sketch.  1.0K 
HMD
Ann: Notification regarding unquoted securities - HMD 		18/02/25 0 197
18/02/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  197 

See All Discussions arrow Created with Sketch.

Timeline

HeraMED to present at NWR Virtual Healthcare Conference
18 Mar 10:58
 
Appendix 4G and Corporate Governance Statement
28 Feb 17:05
 
Annual Report to shareholders
28 Feb 17:00
 
Preliminary Final Report
28 Feb 16:56
 
Strategic Collaboration Agreement with Garmin Health
25 Feb 09:00
 
Investor presentation
19 Feb 11:43
 
View More arrow Created with Sketch.

Featured News

NEWS HotCopper Podcast 006 – What comes first, the bear market or the election?
right-arrow Created with Sketch.
NEWS Q Precious And Battery Metals Mobilizing Diamond Drill La Corne South Project
right-arrow Created with Sketch.
NEWS Patronus Resources Boosts Strategic Holdings with 7.73% Investment in Emmerson Resources
right-arrow Created with Sketch.
NEWS Unseasonal Rains Cause Disruption at Langer Heinrich Mine as Production Temporarily Suspended
right-arrow Created with Sketch.
NEWS Drilling Kicks Off at Highly Prospective Austin Gold Project in WA
right-arrow Created with Sketch.
NEWS Maiden Gold Pour at Laverton Mill Completed as Brightstar’s CY25 Production and Revenue Ramp-Up
right-arrow Created with Sketch.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $13.13M
Open High Low Value Volume
1.5¢ 1.5¢ 1.5¢ $4.875K 325K

Buyers (Bids)

No. Vol. Price($)
2 1079640 1.4¢
 

Sellers (Offers)

Price($) Vol. No.
1.7¢ 1370373 2
View Market Depth
Last trade - 11.20am 21/03/2025 (20 minute delay) ?
HMD (ASX) Chart

Top Stories

Woolworths: We're already taking steps to boost price transparency

Woolworths Group Ltd has responded to a review from the ACCC on pricing transparency, saying it has already met many of the recommendations.
ASX Market Close: Sentiment getting better with finish over 7,900pts Good afternoon and welcome to HotCopper’s Market Close for Thursday, I’m Jonathon Davidson.It was another better-looking day for the bourse as the XJO closed above 7,900 points.
White Cliff inks exploration agreement for multi-mineral play Great Bear White Cliff Minerals Ltd is preparing to commence exploration, after it executed an agreement with the Délınę Got’ınę Government
Expert Exchange: Are we in for another market crash? Recent market volatility can be unnerving; HotCopper asked Andrew Baxter how to read current conditions and if there'll be a market crash.
Kula Gold finds up to 17.9g/t of gold from old mine dumps at Mt Palmer Kula Gold Ltd has seen its share price rise significantly after reporting the presence of high-grade gold from sampling at Mt Palmer

Featured News

NEWS Listen: HotCopper Podcast 005 – It's red, red, red everywhere we look this week
right-arrow Created with Sketch.
NEWS Lucapa Diamond Company Secures Majority Stake in Project Lulo Joint-Venture with Finalization of Mineral Investment Contract
right-arrow Created with Sketch.
NEWS Maiden Gold Pour at Laverton Mill Completed as Brightstar’s CY25 Production and Revenue Ramp-Up
right-arrow Created with Sketch.
NEWS Q Precious And Battery Metals Mobilizing Diamond Drill La Corne South Project
right-arrow Created with Sketch.
NEWS Imugene's Azer-cel Granted FDA Fast Track Designation in Blood Cancer
right-arrow Created with Sketch.
NEWS FDA Approves Telix’s Gozellix for New Prostate Cancer Imaging
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.